Rasagiline

FDA Drug Profile — Rasagiline, RASAGILINE

Rasagiline is listed in the FDA National Drug Code directory with 25 NDC codes, marketed under brand names including Rasagiline, RASAGILINE. Available dosage form: tablet.

Drug details

Generic Name
Rasagiline
Brand Names
Rasagiline, RASAGILINE
Application Number
NDA021641
Sponsor
Teva Pharmaceuticals USA, Inc.
NDC Codes
25
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
RASAGILINE MESYLATE

Indications and Usage

1 INDICATIONS AND USAGE Rasagiline tablets are indicated for the treatment of Parkinson's disease (PD). Rasagiline tablets, a monoamine oxidase (MAO)-B inhibitor (MAOI), is indicated for the treatment of Parkinson’s disease ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.